Ann Dermatol.  2009 Feb;21(1):71-74. 10.5021/ad.2009.21.1.71.

Angiolymphoid Hyperplasia with Eosinophilia That Was Possibly Induced by Vaccination in a Child

Affiliations
  • 1Department of Dermatology, School of Medicine, Chungnam National University, Daejeon, Korea. jhoon@cnu.ac.kr

Abstract

Angiolymphoid hyperplasia with eosinophilia (ALHE) is a rare benign vasoproliferative disease of an unknown cause involving the skin or subcutaneous tissue of the head and neck, and particularly around the ear. It predominantly affects Caucasian adults during the third and fourth decades and it very rarely occurs in children. We experienced a case of ALHE in a 2-year-old Korean boy who had a firm, pruritic, skin-colored, subcutaneous nodule on his right upper arm. The histopathological findings were compatible with ALHE and they showed prominent vascular changes with epitheloid or histiocytoid endothelial cells surrounded by inflammatory cells, including a large proportion of eosinophils. This unusual distribution of the lesion and the young age of the patient may be associated with vaccination.

Keyword

Angiolymphoid hyperplasia with eosinophilia; Child; Vaccination

MeSH Terms

Adult
Angiolymphoid Hyperplasia with Eosinophilia
Arm
Child
Ear
Endothelial Cells
Eosinophils
Head
Humans
Neck
Preschool Child
Skin
Subcutaneous Tissue
Vaccination

Figure

  • Fig. 1 A solitary, firm, skin-colored nodule on the right upper arm.

  • Fig. 2 (A) Several lymphoid aggregates without germinal centers showing lymphocyte and eosinophil infiltration (H&E, ×40). (B) Vascular proliferation with "epitheloid" or "histiocytoid" endothelial cells. There is a cobblestone appearance of enlarged endothelial cells that project into the vessel lumen and a perivascular cellular infiltration that mainly consists of eosinophils and lymphocytes in the dermis (H&E, ×100).

  • Fig. 3 Positive staining for factor VIII-related antigen (immunoperoxidase, ×100) on the walls of the proliferating vessels.

  • Fig. 4 (A) The diffuse, nodular T cell infiltration immunostained for CD3 (immunoperoxidase, ×100) and (B) the small B cell clusters and diffuse infiltration seen with CD20 staining (immunoperoxidase, ×100).


Reference

1. Wells GC, Whimster IW. Subcutaneous angiolymphoid hyperplasia with eosinophilia. Br J Dermatol. 1969. 81:1–14.
Article
2. Kennedy CTC. Champion RH, Burton JL, Burns DA, Breathnach SM, editors. The external ear. Rook/Wilkinson/Ebling textbook of dermatology. 1998. 6th ed. Malden: Blackwell Science;3027–3028.
Article
3. Iguchi Y, Inoue T, Shimono M, Yamamura T, Shigematsu T, Takahashi S. Kimura's disease and its relation to angiolymphoid hyperplasia with eosinophilia: report of three cases and review of the literature. J Oral Pathol. 1986. 15:132–137.
Article
4. Googe PB, Harris NL, Mihm MC Jr. Kimura's disease and angiolymphoid hyperplasia with eosinophilia: two distinct histopathological entities. J Cutan Pathol. 1987. 14:263–271.
Article
5. Mehregan AH, Shapiro L. Angiolymphoid hyperplasia with eosinophilia. Arch Dermatol. 1971. 103:50–57.
Article
6. Rosai J, Gold J, Landy R. The histiocytoid hemangiomas. A unifying concept embracing several previously described entities of skin, soft tissue, large vessels, bone, and heart. Hum Pathol. 1979. 10:707–730.
7. Urabe A, Tsuneyoshi M, Enjoji M. Epithelioid hemangioma versus Kimura's disease. A comparative clinicopathologic study. Am J Surg Pathol. 1987. 11:758–766.
8. Chun SI, Ji HG. Kimura's disease and angiolymphoid hyperplasia with eosinophilia: clinical and histopathologic differences. J Am Acad Dermatol. 1992. 27:954–958.
Article
9. Henry PG, Burnett JW. Angiolymphoid hyperplasia with eosinophilia. Arch Dermatol. 1978. 114:1168–1172.
Article
10. Olsen TG, Helwig EB. Angiolymphoid hyperplasia with eosinophilia. A clinicopathologic study of 116 patients. J Am Acad Dermatol. 1985. 12:781–796.
11. Arnold M, Geilen CC, Coupland SE, Krengel S, Dippel E, Sproder J, et al. Unilateral angiolymphoid hyperplasia with eosinophilia involving the left arm and hand. J Cutan Pathol. 1999. 26:436–440.
Article
12. Akosa AB, Ali MH, Khoo CT, Evans DM. Angiolymphoid hyperplasia with eosinophilia associated with tetanus toxoid vaccination. Histopathology. 1990. 16:589–593.
Article
13. Hallam LA, Mackinlay GA, Wright AM. Angiolymphoid hyperplasia with eosinophilia: possible aetiological role for immunisation. J Clin Pathol. 1989. 42:944–949.
Article
14. Helander SD, Peters MS, Kuo TT, Su WP. Kimura's disease and angiolymphoid hyperplasia with eosinophilia: new observations from immunohistochemical studies of lymphocyte markers, endothelial antigens, and granulocyte proteins. J Cutan Pathol. 1995. 22:319–326.
Article
15. Haas AF, La Perriere R, King E. Angiolymphoid hyperplasia with eosinophilia of the hand. A case report. J Dermatol Surg Oncol. 1991. 17:731–734.
16. Baum EW, Sams WM Jr, Monheit GD. Angiolymphoid hyperplasia with eosinophilia. The disease and a comparison of treatment modalities. J Dermatol Surg Oncol. 1982. 8:966–970.
Article
Full Text Links
  • AD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr